Semaglutide and Tirzepatide could help patients with heart condition HFpEF
Notifications can be managed in browser preferences.
Next article
Semaglutide and Tirzepatide could help patients with heart condition HFpEF
I would like to be emailed about offers, events and updates from The Independent. Read our Privacy notice
The weight loss and type 2 diabetes drugs semaglutide and tirzepatide could slash the risk of patients with a type of heart failure being hospitalised, research shows.
Semaglutide linked to lowering rates of anxiety and depression in new study
Anti-obesity injections like Mounjaro and Wegovy could help people with cardiovascular diseases stay out of hospital and live…
People who are not obese but overweight and at risk of serious cardiovascular events eligible for weekly jabs
Researchers says the drugs could be a treatment for obese people with asthma who are ‘often resistant’ to steroids
GLP-1 drug liraglutide could become a new treatment option for the estimated one in seven people worldwide who live with migraines
GLP-1 agonists could be given to millions with heart conditions to help them stay out of hospital and live longer
